Antibe Therapeutics Inc.
Antibe Therapeutics Inc. (ATBPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATBPF · as of Jun 9, 2026
Key Statistics
Explore Antibe Therapeutics Inc. Data
atbpf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
atbpf competitorsATBPF
CDXFF
CNPOF
EIGRQ
LVCLY
LXXGFStock Performance
Full HistoryAbout Antibe Therapeutics Inc.
Antibe Therapeutics Inc. is a biotechnology company focused on the innovation and development of novel therapeutic solutions and medical devices. The firm operates across Canada, Europe, the United St…
what is antibe therapeutics inc. · atbpf stock overview · antibe therapeutics inc. company profile · who is antibe therapeutics inc. ceo · atbpf OTC · antibe therapeutics inc. headquarters · antibe therapeutics inc. business segments
About Stock Overview & Key Data
Antibe Therapeutics Inc. (ATBPF) is a Healthcare company in the Medical - Devices industry, listed on OTC since Oct 9, 2014. As of the latest trading session, ATBPF stock price is $0.22, with a market capitalization of $11.4M. The stock has returned -0.19% over the past 12 months and -0.19% year-to-date.
In fiscal year 2023, Antibe Therapeutics Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Antibe Therapeutics Inc. (ATBPF) stock price is $0.22. The stock is traded on OTC under the ticker symbol ATBPF. The 52-week range is $0.19 – $0.22.